At the Neuroendocrine Tumor Research Foundation (NETRF), we are dedicated to funding groundbreaking research in neuroendocrine cancer, which includes neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs). Over the years, our efforts have extended far and wide, and we are committed to supporting researchers and institutions across the globe in order to fund the best science possible.
Global Reach
In NETRF’s history, our grant funding has spanned four continents and 16 countries, reflecting our global approach to studying this disease. With 71 institutions benefiting from our grants, we are proud to say that our support has had a worldwide impact. Notably, 33 (47%) of these institutions are located outside of the United States, which have collectively received 41 awards, accounting for 28% of all grants awarded. This distribution underscores our commitment to tapping into the global potential of scientific research and expertise.
Active Engagement in Research Funding
At any given time, we manage approximately 40-50 active awards. This ensures that we continuously support a variety of promising research projects addressing different research topics for neuroendocrine cancer. Each project funded is a step towards new discoveries and treatments, potentially improving patient outcomes in the future.
Continuous Support and Future Directions
Looking ahead, NETRF remains steadfast in its mission to be at the forefront of neuroendocrine cancer research. Our ongoing support for committed researchers and institutions around the world is a pledge to life-changing science. With each grant, we come closer to understanding and eventually defeating neuroendocrine cancer.
As we continue to expand our reach and deepen our impact, we invite our community to join us in this crucial mission. Whether you are a researcher, a donor, or someone affected by neuroendocrine cancer, your support and involvement are vital. Together, we can make a difference in the lives of those affected by this challenging disease.